Analysis of pharmacokinetic data using parametric models. II. Point estimates of an individual's parameters
- PMID: 3834066
- DOI: 10.1007/BF01059333
Analysis of pharmacokinetic data using parametric models. II. Point estimates of an individual's parameters
Abstract
This is the second in a series of tutorial articles discussing the analysis of pharmacokinetic data using parametric models. In this article the basic issue is how to estimate the parameters of such models. Primary emphasis is placed on point estimates of the parameters of the structural (pharmacokinetic) model. All the estimation methods discussed are least squares (LS) methods: ordinary least squares, weighted least squares, iteratively reweighted least squares, and extended least squares. The choice of LS method depends on the variance model. Some discussion is also provided of computer methods used to find the LS estimates, identifiability, and robust LS-based estimation methods.
Similar articles
-
Analysis of pharmacokinetic data using parametric models. III. Hypothesis tests and confidence intervals.J Pharmacokinet Biopharm. 1986 Oct;14(5):539-55. doi: 10.1007/BF01059660. J Pharmacokinet Biopharm. 1986. PMID: 3806375
-
Extended least squares nonlinear regression: a possible solution to the "choice of weights" problem in analysis of individual pharmacokinetic data.J Pharmacokinet Biopharm. 1984 Oct;12(5):545-58. doi: 10.1007/BF01060132. J Pharmacokinet Biopharm. 1984. PMID: 6520748
-
Analysis of pharmacokinetic data using parametric models--1: Regression models.J Pharmacokinet Biopharm. 1984 Feb;12(1):93-117. doi: 10.1007/BF01063613. J Pharmacokinet Biopharm. 1984. PMID: 6747821
-
Estimation of pharmacokinetic parameters: statistical considerations.Pharmacol Ther. 1981;13(3):543-56. doi: 10.1016/0163-7258(81)90029-2. Pharmacol Ther. 1981. PMID: 7025040 Review. No abstract available.
-
Target-mediated drug disposition model: approximations, identifiability of model parameters and applications to the population pharmacokinetic-pharmacodynamic modeling of biologics.Expert Opin Drug Metab Toxicol. 2009 Jul;5(7):803-12. doi: 10.1517/17425250902992901. Expert Opin Drug Metab Toxicol. 2009. PMID: 19505189 Review.
Cited by
-
Identification of patients with impaired hepatic drug metabolism using a limited sampling procedure for estimation of phenazone (antipyrine) pharmacokinetic parameters.Clin Pharmacokinet. 1993 Apr;24(4):333-43. doi: 10.2165/00003088-199324040-00006. Clin Pharmacokinet. 1993. PMID: 8491059 Clinical Trial.
-
Application of optimal sampling theory to the determination of metacycline pharmacokinetic parameters: effect of model misspecification.J Pharmacokinet Biopharm. 1994 Apr;22(2):129-46. doi: 10.1007/BF02353539. J Pharmacokinet Biopharm. 1994. PMID: 7815309
-
Analysis of pharmacokinetic data using parametric models. III. Hypothesis tests and confidence intervals.J Pharmacokinet Biopharm. 1986 Oct;14(5):539-55. doi: 10.1007/BF01059660. J Pharmacokinet Biopharm. 1986. PMID: 3806375
-
Adaptive control methods for the dose individualisation of anticancer agents.Clin Pharmacokinet. 2000 Apr;38(4):315-53. doi: 10.2165/00003088-200038040-00003. Clin Pharmacokinet. 2000. PMID: 10803455 Review.
-
Review of methods and criteria for the evaluation of bioequivalence studies.Eur J Clin Pharmacol. 1990;38(1):5-10. doi: 10.1007/BF00314794. Eur J Clin Pharmacol. 1990. PMID: 2184041 Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical